SCHEMBL3224749

SCHEMBL3224749

CC(C)(C)[Si](C)(C)OCc1c[nH]c2ncnc(Cl)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.44
▸ AURKA O14965 1/20 0.33
▸ TRPA1 O75762 2/20 0.32
▸ IRAK4 Q9NWZ3 2/20 0.32
▸ MAP3K7 O43318 7/20 0.32
▸ TAB1 Q15750 7/20 0.32
▸ NOTUM Q6P988 1/20 0.31
▸ PRKD3 O94806 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ PAK4 O96013 1/20 0.31
▸ NTRK1 P04629 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ LTK P29376 1/20 0.31
▸ MAP2K2 P36507 1/20 0.31
▸ MAPK8 P45983 1/20 0.31
▸ CDK8 P49336 1/20 0.31
▸ CLK2 P49760 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3285768 0.87 CHEK1 (0.42) CHEK1AURKATRPA1IRAK4MAP3K7
SCHEMBL31618054 0.85 CHEK1 (0.40) CHEK1AURKATRPA1IRAK4PRKD3
SCHEMBL13005543 0.85 CHEK1 (0.40) CHEK1AURKATRPA1IRAK4PRKD3
SCHEMBL3372101 0.80 CHEK1 (0.40) CHEK1AURKAMAP3K7TAB1AKT1
SCHEMBL20195284 0.77 CHEK1 (0.49) CHEK1AURKATRPA1IRAK4MAP3K7
SCHEMBL4780230 0.75 CHEK1 (0.56) CHEK1AURKATRPA1IRAK4MAP3K7
SCHEMBL16765141 0.74 CHEK1 (0.49) CHEK1AURKATRPA1IRAK4MAP3K7
SCHEMBL24345183 0.73 CHEK1 (0.58) CHEK1AURKATRPA1IRAK4MAP3K7
SCHEMBL27804119 0.72 CHEK1 (0.46) CHEK1TRPA1IRAK4MAP3K7TAB1
SCHEMBL2783376 0.72 CHEK1 (0.53) CHEK1AURKATRPA1IRAK4MAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010015637-A1 NEW ANTIVIRAL MODIFIED NUCLEOSIDES NOVARTIS AG (CH) 2010-02-11 — — WO disclosed
WO-2010015637-A1 NEW ANTIVIRAL MODIFIED NUCLEOSIDES NOVARTIS AG (CH) 2010-02-11 — — WO disclosed
Send feedback